![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Enhanced Biopharmaceutical Release: Autonomous PAT Power
Speeding up biomanufacturing using automated Process Analytical Technology (PAT) systems
A2P2 and Micro Sequential Injection (SI),...
Overcoming Treatment Challenges With Cell And Gene Therapies
Gene and cell therapies have the potential to revolutionize healthcare by reprogramming the immune system...
Boosting Innovation And Value In UK Biopharma And Medtech
New recommendations from Imperial College London aim to boost competitiveness in the UK's biopharma and...
Cell And Gene Therapy CDMO Services Market Is On The Rise
The global cell and gene therapy Contract Development and Manufacturing Organization (CDMO) services market, which...
What’s driving the growth of the biopharma sector across South East Asia?
Standfirst: The healthcare industry, particularly the life-science and biopharma sectors, across ASEAN is seeing a...
Lack of Experience Hinders CDMOs In Cell And Gene Therapy
CDMOs (contract development and manufacturing organizations) are facing challenges due to the increasing number of...
Cell and Gene Therapy CDMO Targets North American Growth with Major US Acquisition
uBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into...
Biopharma Spectrum To Be Driven By Automation In Next Decade
One of the reports concerning automation in the biopharmaceutical sector has gone on to show...
New UK Biotech Centres To Boost Cell And Gene Therapies
The National Health Service Blood and Transplant from the UK, which takes care of blood...
Emmes Launches Cell and Gene Therapy Center
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public...